Radioresistant Cervical Cancers Are Sensitive to Inhibition of Glycolysis and Redox Metabolism.

Abstract:

:Highly glycolytic cervical cancers largely resist treatment by cisplatin and coadministered pelvic irradiation as the present standard of care. In this study, we investigated the effects of inhibiting glycolysis and thiol redox metabolism to evaluate them as alternate treatment strategies in these cancers. In a panel of multiple cervical cancer cell lines, we evaluated sensitivity to inhibition of glycolysis (2-deoxyglucose, 2-DG) with or without simultaneous inhibition of glutathione and thioredoxin metabolism (BSO/AUR). Intracellular levels of total and oxidized glutathione, thioredoxin reductase activity, and indirect measures of intracellular reactive oxygen species were compared before and after treatment. Highly radioresistant cells were the most sensitive to 2-DG, whereas intermediate radioresistant cells were sensitive to 2-DG plus BSO/AUR. In response to 2-DG/BSO/AUR treatment, we observed increased levels of intracellular oxidized glutathione, redox-sensitive dye oxidation, and decreased glucose utilization via multiple metabolic pathways including the tricarboxylic acid cycle. 2-DG/BSO/AUR treatment delayed the growth of tumors composed of intermediate radioresistant cells and effectively radiosensitized these tumors at clinically relevant radiation doses both in vitro and in vivo Overall, our results support inhibition of glycolysis and intracellular redox metabolism as an effective alternative drug strategy for the treatment of highly glycolytic and radioresistant cervical cancers.Significance: This study suggests a simple metabolic approach to strike at an apparent Achilles' heel in highly glycolytic, radioresistant forms of cervical cancers, possibly with broader applications in cancer therapy. Cancer Res; 78(6); 1392-403. ©2018 AACR.

journal_name

Cancer Res

journal_title

Cancer research

authors

Rashmi R,Huang X,Floberg JM,Elhammali AE,McCormick ML,Patti GJ,Spitz DR,Schwarz JK

doi

10.1158/0008-5472.CAN-17-2367

subject

Has Abstract

pub_date

2018-03-15 00:00:00

pages

1392-1403

issue

6

eissn

0008-5472

issn

1538-7445

pii

0008-5472.CAN-17-2367

journal_volume

78

pub_type

杂志文章
  • Long-Chain n-3 Fatty Acids Attenuate Oncogenic KRas-Driven Proliferation by Altering Plasma Membrane Nanoscale Proteolipid Composition.

    abstract::Ras signaling originates from transient nanoscale compartmentalized regions of the plasma membrane composed of specific proteins and lipids. The highly specific lipid composition of these nanodomains, termed nanoclusters, facilitates effector recruitment and therefore influences signal transduction. This suggests that...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-18-0324

    authors: Fuentes NR,Mlih M,Barhoumi R,Fan YY,Hardin P,Steele TJ,Behmer S,Prior IA,Karpac J,Chapkin RS

    更新日期:2018-07-15 00:00:00

  • Identification of a positive regulatory element responsible for tissue-specific expression of prostate-specific antigen.

    abstract::The prostate-specific antigen (PSA) promoter (PSA-P) has been identified, characterized, and determined to be tissue specific. Compared with high expression of the genomic PSA gene in prostate cells, expression of the transgene driven by the putative PSA promoter is low. This suggests that the identified promoter may ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Pang S,Dannull J,Kaboo R,Xie Y,Tso CL,Michel K,deKernion JB,Belldegrun AS

    更新日期:1997-02-01 00:00:00

  • Dose-related endocrine effects and pharmacokinetics of oral and intramuscular 4-hydroxyandrostenedione in postmenopausal breast cancer patients.

    abstract::4-Hydroxyandrostenedione (CGP32349; 4-OHA) is a clinically effective treatment for advanced postmenopausal breast cancer by both the parenteral and p.o. routes, as a result of its inhibition of aromatase and consequent suppression of plasma estrogen levels. Thirty patients were randomized to treatment with 250 mg 4-OH...

    journal_title:Cancer research

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:

    authors: Dowsett M,Cunningham DC,Stein RC,Evans S,Dehennin L,Hedley A,Coombes RC

    更新日期:1989-03-01 00:00:00

  • Monoclonal antibodies recognizing oval cells induced in the liver of rats by N-2-fluorenylacetamide or ethionine in a choline-deficient diet.

    abstract::In this paper, we describe the production of a panel of monoclonal antibodies which define antigens which distinguish between hepatocytes and oval cells. These antibodies were obtained from hybridomas constructed from the spleens of mice immunized by a novel protocol designed to suppress response to unwanted or immuno...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Hixson DC,Allison JP

    更新日期:1985-08-01 00:00:00

  • Human leukemia cell lines with comparable receptor binding characteristics but different phenotypic responses to phorbol diesters.

    abstract::Phorbol diester (PDE) tumor promoters have differing effects on normal and neoplastic hematopoietic cells in vitro. The effects of PDEs on cells are apparently mediated by specific cellular receptors for these ligands. The purpose of this study was to determine if the different phenotypic responses of cells of differe...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Weinberg JB,Misukonis MA,Goodwin BJ

    更新日期:1984-03-01 00:00:00

  • 2-Methoxyestradiol suppresses osteolytic breast cancer tumor progression in vivo.

    abstract::2-Methoxyestradiol (2ME(2)), a physiologic metabolite of 17beta-estradiol (estrogen), has emerged as a promising cancer therapy because of its potent growth-inhibitory and proapoptotic effects on both endothelial and tumor cells. 2ME(2) also suppresses osteoclast differentiation and induces apoptosis of mature osteocl...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-07-1362

    authors: Cicek M,Iwaniec UT,Goblirsch MJ,Vrabel A,Ruan M,Clohisy DR,Turner RR,Oursler MJ

    更新日期:2007-11-01 00:00:00

  • Promoting Scientist-Advocate Collaborations in Cancer Research: Why and How.

    abstract::Advocates bring unique and important viewpoints to the cancer research process, ensuring that scientific and medical advances are patient-centered and relevant. In this article, we discuss the benefits of engaging advocates in cancer research and underscore ways in which both the scientific and patient communities can...

    journal_title:Cancer research

    pub_type: 杂志文章,评审

    doi:10.1158/0008-5472.CAN-18-1600

    authors: Salamone JM,Lucas W,Brundage SB,Holloway JN,Stahl SM,Carbine NE,London M,Greenwood N,Goyes R,Chisholm DC,Price E,Carlin R,Winarsky S,Baker KB,Maues J,Shajahan-Haq AN

    更新日期:2018-10-15 00:00:00

  • Mimicry of a cellular low energy status blocks tumor cell anabolism and suppresses the malignant phenotype.

    abstract::Aggressive cancer cells typically show a high rate of energy-consuming anabolic processes driving the synthesis of lipids, proteins, and DNA. Here, we took advantage of the ability of the cell-permeable nucleoside 5-aminoimidazole-4-carboxamide (AICA) riboside to increase the intracellular levels of AICA ribotide, an ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-04-3025

    authors: Swinnen JV,Beckers A,Brusselmans K,Organe S,Segers J,Timmermans L,Vanderhoydonc F,Deboel L,Derua R,Waelkens E,De Schrijver E,Van de Sande T,Noël A,Foufelle F,Verhoeven G

    更新日期:2005-03-15 00:00:00

  • CD10 is a key enzyme involved in the activation of tumor-activated peptide prodrug CPI-0004Na and novel analogues: implications for the design of novel peptide prodrugs for the therapy of CD10+ tumors.

    abstract::Traditional chemotherapeutic drugs are often restricted by severe side effects and lack of tumor specificity. Peptide prodrugs cleavable by peptidases present in the tumor environment have been explored to improve the therapeutic index of cytotoxic drugs. One such prodrug of doxorubicin (Dox), CPI-0004Na [N-succinyl-b...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Pan C,Cardarelli PM,Nieder MH,Pickford LB,Gangwar S,King DJ,Yarranton GT,Buckman D,Roscoe W,Zhou F,Salles A,Chen TH,Horgan K,Wang YH,Nguyen T,Bebbington CR

    更新日期:2003-09-01 00:00:00

  • Effects of butyrate on epidermal growth factor receptor binding, morphology, and DNA synthesis in cultured rat hepatocytes.

    abstract::We have examined the effect of butyrate on morphology, DNA synthesis, and epidermal growth factor (EGF) receptor binding in primary cultures of rat hepatocytes. Butyrate added 2 h after plating retarded the flattening and maintained the polyhedral shape of the hepatocytes in culture. Both insulin- and EGF-stimulated D...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Gladhaug IP,Refsnes M,Sand TE,Christoffersen T

    更新日期:1988-11-15 00:00:00

  • CHK1 Inhibition Is Synthetically Lethal with Loss of B-Family DNA Polymerase Function in Human Lung and Colorectal Cancer Cells.

    abstract::Checkpoint kinase 1 (CHK1) is a key mediator of the DNA damage response that regulates cell-cycle progression, DNA damage repair, and DNA replication. Small-molecule CHK1 inhibitors sensitize cancer cells to genotoxic agents and have shown single-agent preclinical activity in cancers with high levels of replication st...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-19-1372

    authors: Rogers RF,Walton MI,Cherry DL,Collins I,Clarke PA,Garrett MD,Workman P

    更新日期:2020-04-15 00:00:00

  • Sulindac sulfide-induced apoptosis involves death receptor 5 and the caspase 8-dependent pathway in human colon and prostate cancer cells.

    abstract::Sulindac is the most extensively investigated clinically relevant chemopreventive nonsteroidal anti-inflammatory drug. Sulindac sulfide is one of the major metabolites of sulindac that is believed to mediate its antitumorigenic effects by inducing apoptosis. Recent evidence suggests that sulindac sulfide engages the m...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Huang Y,He Q,Hillman MJ,Rong R,Sheikh MS

    更新日期:2001-09-15 00:00:00

  • Total serum cholesterol and triglycerides and risk of breast cancer: a prospective study of 24,329 Norwegian women.

    abstract::The association between total serum cholesterol and triglycerides and the incidence rate of breast cancer has been examined in 242 incident cases of breast cancer that developed among 24,329 Norwegian women during 11-14 years of follow-up. At the time of lipid measurement they were between 35 and 51 years of age. Ther...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Vatten LJ,Foss OP

    更新日期:1990-04-15 00:00:00

  • Determinants of activity of the antifolate thymidylate synthase inhibitors Tomudex (ZD1694) and GW1843U89 against mono- and multilayered colon cancer cell lines under folate-restricted conditions.

    abstract::The cytotoxicity and metabolic effects of two thymidylate synthase (TS) inhibitors, Tomudex (Raltitrexed, ZD1694) and GW1843U89, were studied in WiDr colon cancer cells under four different growth conditions: as standard monolayers and as postconfluent multilayers grown under either high (WiDr, 8.8 microM folic acid) ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Peters GJ,Smitskamp-Wilms E,Smid K,Pinedo HM,Jansen G

    更新日期:1999-11-01 00:00:00

  • Quantitative assessment of generalized epithelial changes in tracheal mucosa following exposure to 7,12-dimethylbenz(a)anthracene.

    abstract::Sequential morphological changes occurring after brief carcinogen exposures of heterotopic tracheal transplants in rats were semiquantitatively studied. Tracheas were exposed to 7,12-dimethylbenz(a)anthracene for 1, 2, or 4 weeks, during which time means of 138, 152, and 160 microgram 7,12-dimethylbenz(a)anthracene, r...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Topping DC,Griesemer RA,Nettesheim P

    更新日期:1979-12-01 00:00:00

  • Molecular genetic characterization of BRCA1- and BRCA2-linked hereditary ovarian cancers.

    abstract::Hereditary ovarian cancers associated with germline mutations in either BRCA1 or BRCA2 were studied to determine whether somatic mutation of the P53 gene is required for BRCA-linked ovarian tumorigenesis and further, whether the spectrum of additional somatic molecular genetic alterations present in these tumors diffe...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Rhei E,Bogomolniy F,Federici MG,Maresco DL,Offit K,Robson ME,Saigo PE,Boyd J

    更新日期:1998-08-01 00:00:00

  • Endogenous interleukin-4 promotes tumor development by increasing tumor cell resistance to apoptosis.

    abstract::The increase of interleukin-4 (IL-4) level in tumor environment and the up-regulation of IL-4 receptor (IL-4R) on tumor cells have been long observed. However, their significance for tumor development has not been investigated. Here, we found that endogenous IL-4 promotes tumor growth because neutralizing IL-4 by 11B1...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-08-0449

    authors: Li Z,Jiang J,Wang Z,Zhang J,Xiao M,Wang C,Lu Y,Qin Z

    更新日期:2008-11-01 00:00:00

  • Suppression of mammary carcinoma cell growth by retinoic acid: the cell cycle control gene Btg2 is a direct target for retinoic acid receptor signaling.

    abstract::The anticarcinogenic activities of retinoic acid (RA) are believed to be mediated by the nuclear RA receptor (RAR) and by the RA-binding protein cellular RA-binding protein-II (CRABP-II). In MCF-7 mammary carcinoma cells, growth inhibition by RA entails an early cell cycle arrest followed by induction of apoptosis. He...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-06-0989

    authors: Donato LJ,Suh JH,Noy N

    更新日期:2007-01-15 00:00:00

  • Epigenetic mechanisms of promigratory chemokine CXCL14 regulation in human prostate cancer cells.

    abstract::Chemokines play the key role in initiating immune responses by regulating the attraction and homing of immune cells to the lymphoid and nonlymphoid tissues. CXCL14 is a chemokine that in tumors may act as chemoattractant for monocytes and dendritic cells (DC), which may modulate antitumor immune responses in certain c...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-10-0427

    authors: Song EY,Shurin MR,Tourkova IL,Gutkin DW,Shurin GV

    更新日期:2010-06-01 00:00:00

  • Difference in the response of neu and ras oncogene-induced rat mammary carcinomas to early and late ovariectomy.

    abstract::Rat mammary carcinomas were induced by directly inserting activated neu or ras genes into in situ rat mammary ductal cells using replication-defective retroviral vectors. neu was over 200 times more potent than ras in inducing rat mammary carcinomas. Ovariectomy 2 days postinfection dramatically reduced the occurrence...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Wang B,Kennan WS,Yasukawa-Barnes J,Lindstrom MJ,Gould MN

    更新日期:1992-08-01 00:00:00

  • Sp3, but not Sp1, mediates the transcriptional activation of the p21/WAF1/Cip1 gene promoter by histone deacetylase inhibitor.

    abstract::We previously reported that both sodium butyrate and trichostatin A (TSA), both of which are known as inhibitors of histone deacetylase, arrest human tumor cells at G1 and G2-M and activate the cyclin-dependent kinase inhibitor, the p21/WAF1/Cip1 gene promoter, through the Sp1 sites. In this study, we identified Sp1 a...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Sowa Y,Orita T,Minamikawa-Hiranabe S,Mizuno T,Nomura H,Sakai T

    更新日期:1999-09-01 00:00:00

  • Immunocytochemical detection of interaction products of cis-diamminedichloroplatinum(II) and cis-diammine(1,1-cyclobutanedicarboxylato)platinum(II) with DNA in rodent tissue sections.

    abstract::Calf thymus DNA was modified in vitro by cis-diamminedichloroplatinum(II) (cisDDP), complexed with methylated bovine serum albumin and used to immunize rabbits. The anti-cisDDP-DNA antiserum obtained was applied in a double peroxidase-antiperoxidase staining procedure to localize cisDDP-DNA and cis-diammine(1,1-cyclob...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Terheggen PM,Floot BG,Scherer E,Begg AC,Fichtinger-Schepman AM,den Engelse L

    更新日期:1987-12-15 00:00:00

  • Intercapillary distance in the proliferating area of human glioma.

    abstract::Tissues from 22 patients with glioma and 7 patients with normal white matter were used in this study. First we determined the proliferating area in the tumor tissue by evaluating the growth fraction (GF). Second we determined the mean number of cells and measured the intercapillary distance in a modified tumor cord in...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Yoshii Y,Sugiyama K

    更新日期:1988-05-15 00:00:00

  • Indibulin, a novel microtubule inhibitor, discriminates between mature neuronal and nonneuronal tubulin.

    abstract::Microtubule inhibitors interfere with microtubule dynamics, causing cell cycle arrest and apoptosis. These effects are responsible for the chemotherapeutic activities of members of the taxane and Vinca alkaloid families in oncology. Unfortunately, a major side effect of the taxanes and Vinca alkaloids is the developme...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-08-1342

    authors: Wienecke A,Bacher G

    更新日期:2009-01-01 00:00:00

  • In vitro migration of lymphocytes through collagen matrix: arrested locomotion in tumor-infiltrating lymphocytes.

    abstract::Antitumor immunity requires (a) extravasation of lymphocytes from the blood stream to interstitium, (b) locomotion through extracellular matrix to the site of the tumor, (c) effector cell recognition of the tumor target with cell/cell contact and binding of adhesion receptors, (d) T-cell receptor binding to histocompa...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Applegate KG,Balch CM,Pellis NR

    更新日期:1990-11-15 00:00:00

  • p53-inducible ribonucleotide reductase (p53R2/RRM2B) is a DNA hypomethylation-independent decitabine gene target that correlates with clinical response in myelodysplastic syndrome/acute myelogenous leukemia.

    abstract::While the therapeutic activity of the deoxycytidine analogue decitabine is thought to reflect its ability to reactivate methylation-silenced genes, this agent is also known to trigger p53-dependent DNA damage responses. Here, we report that p53-inducible ribonucleotide reductase (p53R2/RRM2B) is a robust transcription...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-08-1860

    authors: Link PA,Baer MR,James SR,Jones DA,Karpf AR

    更新日期:2008-11-15 00:00:00

  • Role of cytoplasmic lipids in altering diphenylhexatriene fluorescence polarization in malignant cells.

    abstract::Prior studies of fluorescence anisotropy (polarization) with diphenylhexatriene in normal and malignant cell populations have shown differences which have been attributed to an altered membrane lipid composition in cancer. We studied fresh tumor cells from patients with diverse lymphoid neoplasms and found a discrete ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Spiegel RJ,Magrath IT,Shutta JA

    更新日期:1981-02-01 00:00:00

  • Expression of growth factors and oncogenes in normal and tumor-derived human mammary epithelial cells.

    abstract::The expression of genes which may be involved in the regulation of human mammary epithelial cell growth [transforming growth factors alpha and beta] and tumorigenesis [c-myc, erbB2, epidermal growth factor receptor (EGFR), Ha-ras, pS2] has been compared in similarly cultured normal cell strains and tumor cell lines. W...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Zajchowski D,Band V,Pauzie N,Tager A,Stampfer M,Sager R

    更新日期:1988-12-15 00:00:00

  • Prognostically important chromosomal aberrations in soft tissue sarcomas: a report of the Chromosomes and Morphology (CHAMP) Study Group.

    abstract::Cytogenetic analysis has not only provided important information on the pathogenesis of soft tissue tumors but, by disclosing distinct chromosomal rearrangements in different histopathological entities, has also come to serve as a valuable diagnostic tool. Little is known as yet about the potential prognostic impact o...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Mertens F,Strömberg U,Mandahl N,Dal Cin P,De Wever I,Fletcher CD,Mitelman F,Rosai J,Rydholm A,Sciot R,Tallini G,Van Den Berghe H,Vanni R,Willén H

    更新日期:2002-07-15 00:00:00

  • Maintenance of p53 alterations throughout breast cancer progression.

    abstract::Overexpression of the nuclear phosphoprotein p53 is one of the most common abnormalities in primary human cancer and appears to be due to point mutation within a highly conserved region of the p53 gene which then encodes for a mutant, more stable protein. In this study different stages of breast cancer progression wer...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Davidoff AM,Kerns BJ,Iglehart JD,Marks JR

    更新日期:1991-05-15 00:00:00